DRG 266

Surgical DRG

Endovascular Cardiac Valve Replacement and Supplement Procedures with MCC

TypeSurgicalMDC05

What is MS-DRG 266?

MS-DRG 266 is a Surgical Medicare Severity Diagnosis Related Group under Major Diagnostic Category 05 (MDC 05) with a Major Complication or Comorbidity (MCC). Hospitals use this grouping to determine reimbursement for inpatient stays under Medicare.

Classification
Surgical DRG
Procedure-driven grouping
Linked Codes
0 diagnosis
66 procedure

Linked ICD-10-PCS Procedure Mappings

  • 02RF37H

    Replacement of Aortic Valve with Autologous Tissue Substitute, Transapical, Percutaneous Approach

    BillableSection 0
  • 02RF37Z

    Replacement of Aortic Valve with Autologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02RF38H

    Replacement of Aortic Valve with Zooplastic Tissue, Transapical, Percutaneous Approach

    BillableSection 0
  • 02RF38N

    Replacement of Aortic Valve with Zooplastic Tissue, using Rapid Deployment Technique, Percutaneous Approach

    BillableSection 0
  • 02RF38Z

    Replacement of Aortic Valve with Zooplastic Tissue, Percutaneous Approach

    BillableSection 0
  • 02RF3JH

    Replacement of Aortic Valve with Synthetic Substitute, Transapical, Percutaneous Approach

    BillableSection 0
  • 02RF3JZ

    Replacement of Aortic Valve with Synthetic Substitute, Percutaneous Approach

    BillableSection 0
  • 02RF3KH

    Replacement of Aortic Valve with Nonautologous Tissue Substitute, Transapical, Percutaneous Approach

    BillableSection 0
  • 02RF3KZ

    Replacement of Aortic Valve with Nonautologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02RG37H

    Replacement of Mitral Valve with Autologous Tissue Substitute, Transapical, Percutaneous Approach

    BillableSection 0
  • 02RG37Z

    Replacement of Mitral Valve with Autologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02RG38H

    Replacement of Mitral Valve with Zooplastic Tissue, Transapical, Percutaneous Approach

    BillableSection 0
  • 02RG38Z

    Replacement of Mitral Valve with Zooplastic Tissue, Percutaneous Approach

    BillableSection 0
  • 02RG3JH

    Replacement of Mitral Valve with Synthetic Substitute, Transapical, Percutaneous Approach

    BillableSection 0
  • 02RG3JZ

    Replacement of Mitral Valve with Synthetic Substitute, Percutaneous Approach

    BillableSection 0
  • 02RG3KH

    Replacement of Mitral Valve with Nonautologous Tissue Substitute, Transapical, Percutaneous Approach

    BillableSection 0
  • 02RG3KZ

    Replacement of Mitral Valve with Nonautologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02RH37H

    Replacement of Pulmonary Valve with Autologous Tissue Substitute, Transapical, Percutaneous Approach

    BillableSection 0
  • 02RH37Z

    Replacement of Pulmonary Valve with Autologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02RH38H

    Replacement of Pulmonary Valve with Zooplastic Tissue, Transapical, Percutaneous Approach

    BillableSection 0
  • 02RH38L

    Replacement of Pulmonary Valve with Zooplastic Tissue, In Existing Conduit, Percutaneous Approach

    BillableSection 0
  • 02RH38M

    Replacement of Pulmonary Valve with Zooplastic Tissue, Native Site, Percutaneous Approach

    BillableSection 0
  • 02RH38Z

    Replacement of Pulmonary Valve with Zooplastic Tissue, Percutaneous Approach

    BillableSection 0
  • 02RH3JH

    Replacement of Pulmonary Valve with Synthetic Substitute, Transapical, Percutaneous Approach

    BillableSection 0
  • 02RH3JZ

    Replacement of Pulmonary Valve with Synthetic Substitute, Percutaneous Approach

    BillableSection 0
  • 02RH3KH

    Replacement of Pulmonary Valve with Nonautologous Tissue Substitute, Transapical, Percutaneous Approach

    BillableSection 0
  • 02RH3KZ

    Replacement of Pulmonary Valve with Nonautologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02RJ37H

    Replacement of Tricuspid Valve with Autologous Tissue Substitute, Transapical, Percutaneous Approach

    BillableSection 0
  • 02RJ37Z

    Replacement of Tricuspid Valve with Autologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02RJ38H

    Replacement of Tricuspid Valve with Zooplastic Tissue, Transapical, Percutaneous Approach

    BillableSection 0
  • 02RJ38Z

    Replacement of Tricuspid Valve with Zooplastic Tissue, Percutaneous Approach

    BillableSection 0
  • 02RJ3JH

    Replacement of Tricuspid Valve with Synthetic Substitute, Transapical, Percutaneous Approach

    BillableSection 0
  • 02RJ3JZ

    Replacement of Tricuspid Valve with Synthetic Substitute, Percutaneous Approach

    BillableSection 0
  • 02RJ3KH

    Replacement of Tricuspid Valve with Nonautologous Tissue Substitute, Transapical, Percutaneous Approach

    BillableSection 0
  • 02RJ3KZ

    Replacement of Tricuspid Valve with Nonautologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02UF37J

    Supplement Aortic Valve created from Truncal Valve with Autologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02UF37Z

    Supplement Aortic Valve with Autologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02UF38J

    Supplement Aortic Valve created from Truncal Valve with Zooplastic Tissue, Percutaneous Approach

    BillableSection 0
  • 02UF38Z

    Supplement Aortic Valve with Zooplastic Tissue, Percutaneous Approach

    BillableSection 0
  • 02UF3JJ

    Supplement Aortic Valve created from Truncal Valve with Synthetic Substitute, Percutaneous Approach

    BillableSection 0
  • 02UF3JZ

    Supplement Aortic Valve with Synthetic Substitute, Percutaneous Approach

    BillableSection 0
  • 02UF3KJ

    Supplement Aortic Valve created from Truncal Valve with Nonautologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02UF3KZ

    Supplement Aortic Valve with Nonautologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02UG37E

    Supplement Mitral Valve created from Left Atrioventricular Valve with Autologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02UG37Z

    Supplement Mitral Valve with Autologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02UG38E

    Supplement Mitral Valve created from Left Atrioventricular Valve with Zooplastic Tissue, Percutaneous Approach

    BillableSection 0
  • 02UG38Z

    Supplement Mitral Valve with Zooplastic Tissue, Percutaneous Approach

    BillableSection 0
  • 02UG3JE

    Supplement Mitral Valve created from Left Atrioventricular Valve with Synthetic Substitute, Percutaneous Approach

    BillableSection 0
  • 02UG3JH

    Supplement Mitral Valve with Synthetic Substitute, Transapical, Percutaneous Approach

    BillableSection 0
  • 02UG3JZ

    Supplement Mitral Valve with Synthetic Substitute, Percutaneous Approach

    BillableSection 0
  • 02UG3KE

    Supplement Mitral Valve created from Left Atrioventricular Valve with Nonautologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02UG3KZ

    Supplement Mitral Valve with Nonautologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02UH37Z

    Supplement Pulmonary Valve with Autologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02UH38Z

    Supplement Pulmonary Valve with Zooplastic Tissue, Percutaneous Approach

    BillableSection 0
  • 02UH3JZ

    Supplement Pulmonary Valve with Synthetic Substitute, Percutaneous Approach

    BillableSection 0
  • 02UH3KZ

    Supplement Pulmonary Valve with Nonautologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02UJ37G

    Supplement Tricuspid Valve created from Right Atrioventricular Valve with Autologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02UJ37Z

    Supplement Tricuspid Valve with Autologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02UJ38G

    Supplement Tricuspid Valve created from Right Atrioventricular Valve with Zooplastic Tissue, Percutaneous Approach

    BillableSection 0
  • 02UJ38Z

    Supplement Tricuspid Valve with Zooplastic Tissue, Percutaneous Approach

    BillableSection 0
  • 02UJ3JG

    Supplement Tricuspid Valve created from Right Atrioventricular Valve with Synthetic Substitute, Percutaneous Approach

    BillableSection 0
  • 02UJ3JZ

    Supplement Tricuspid Valve with Synthetic Substitute, Percutaneous Approach

    BillableSection 0
  • 02UJ3KG

    Supplement Tricuspid Valve created from Right Atrioventricular Valve with Nonautologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02UJ3KZ

    Supplement Tricuspid Valve with Nonautologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • X2RJ3RA

    Replacement of Tricuspid Valve with Multi-plane Flex Technology Bioprosthetic Valve, Percutaneous Approach, New Technology Group 10

    BillableSection X
  • X2U93YA

    Supplement Right Atrium with Intraluminal Device, Heterotopic Bioprosthetic Valve(s), Percutaneous Approach, New Technology Group 10

    BillableSection X